Ownership Capital B.V. Has $29.84 Million Stock Position in Medidata Solutions Inc (NASDAQ:MDSO)

Ownership Capital B.V. lowered its holdings in Medidata Solutions Inc (NASDAQ:MDSO) by 43.5% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 329,673 shares of the company’s stock after selling 254,052 shares during the quarter. Medidata Solutions accounts for about 1.3% of Ownership Capital B.V.’s investment portfolio, making the stock its 23rd largest position. Ownership Capital B.V. owned about 0.53% of Medidata Solutions worth $29,839,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Securian Asset Management Inc grew its holdings in Medidata Solutions by 1.5% in the 1st quarter. Securian Asset Management Inc now owns 7,587 shares of the company’s stock valued at $556,000 after buying an additional 113 shares during the last quarter. Municipal Employees Retirement System of Michigan grew its holdings in Medidata Solutions by 1.1% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 11,510 shares of the company’s stock valued at $1,042,000 after buying an additional 120 shares during the last quarter. Flagship Harbor Advisors LLC grew its holdings in Medidata Solutions by 58.3% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 475 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the last quarter. Zions Bancorporation N.A. grew its holdings in Medidata Solutions by 5.9% in the 2nd quarter. Zions Bancorporation N.A. now owns 3,521 shares of the company’s stock valued at $319,000 after buying an additional 195 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in Medidata Solutions by 2.2% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,971 shares of the company’s stock valued at $804,000 after buying an additional 234 shares during the last quarter. 96.04% of the stock is currently owned by hedge funds and other institutional investors.

Shares of MDSO stock traded up $0.08 during mid-day trading on Thursday, reaching $91.47. The stock had a trading volume of 46,362 shares, compared to its average volume of 977,563. The company has a 50 day moving average of $90.99. The company has a current ratio of 2.56, a quick ratio of 2.56 and a debt-to-equity ratio of 0.27. Medidata Solutions Inc has a one year low of $60.10 and a one year high of $98.60. The company has a market capitalization of $5.70 billion, a price-to-earnings ratio of 95.30, a PEG ratio of 6.03 and a beta of 1.23.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Monday, July 22nd. The company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.17 by $0.31. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The company had revenue of $180.50 million during the quarter, compared to the consensus estimate of $179.95 million. During the same quarter last year, the company earned $0.43 EPS. The company’s quarterly revenue was up 15.8% on a year-over-year basis. As a group, sell-side analysts expect that Medidata Solutions Inc will post 0.8 earnings per share for the current year.

A number of analysts have issued reports on MDSO shares. SunTrust Banks raised their target price on Medidata Solutions from $85.00 to $92.25 and gave the company a “hold” rating in a report on Thursday, June 13th. Guggenheim lowered Medidata Solutions from a “buy” rating to a “neutral” rating and set a $92.25 target price on the stock. in a report on Wednesday, June 12th. Wells Fargo & Co reaffirmed a “hold” rating on shares of Medidata Solutions in a report on Thursday, June 13th. Dougherty & Co downgraded Medidata Solutions from a “buy” rating to a “neutral” rating in a research report on Wednesday, May 1st. Finally, Piper Jaffray Companies downgraded Medidata Solutions from an “overweight” rating to a “neutral” rating in a research report on Wednesday, June 12th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. Medidata Solutions has a consensus rating of “Hold” and an average target price of $84.27.

In related news, Director Robert Taylor sold 3,294 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $90.88, for a total transaction of $299,358.72. Following the completion of the transaction, the director now owns 41,757 shares in the company, valued at approximately $3,794,876.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 4.70% of the stock is currently owned by company insiders.

Medidata Solutions Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Article: Economic Bubble

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit